Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy

An impediment to mucositis research has been the lack of an accepted, validated scoring system. The objective of this study was to design, test, and validate a new scoring system for mucositis that can be used easily, is reproducible, and provides an accurate system for research applications.

[1]  S. Sonis,et al.  The impact of mucositis on α‐hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies , 1998, Cancer.

[2]  N. Facione,et al.  Comparison of methods to determine the prevalence and nature of oral mucositis. , 1996, Cancer practice.

[3]  J. Haley,et al.  Section Reviews: Biologicals & Immunologicals: Pharmacological attenuation of chemotherapy-induced oral mucositis , 1996 .

[4]  F M Muggia,et al.  Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Armitage,et al.  Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  N. Kemeny,et al.  Uridine allows dose escalation of 5‐fluorouracil when given with N‐phosphonacetyl‐L‐Aspartate, methotrexate, and leucovorin , 1993, Cancer.

[7]  L. Elting,et al.  Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  G. Donaldson,et al.  Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation development of an oral mucositis index , 1992, Cancer.

[9]  J. Crowley,et al.  Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: a Southwest Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Denham,et al.  Concurrent cisplatin, infusional fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer: dose-limiting mucosal toxicity. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Sloan,et al.  Development of a staging system for chemotherapy‐induced stomatitis: Western Consortium for Cancer Nursing Research , 1991, Cancer nursing.

[12]  F. Spijkervet,et al.  Scoring irradiation mucositis in head and neck cancer patients. , 1989, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[13]  A. Berger,et al.  Development, testing, and application of the oral assessment guide. , 1988, Oncology nursing forum.

[14]  S. Sonis,et al.  Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. , 1998, Oral oncology.